Page last updated: 2024-11-08

isoflurophate and Hepatic Encephalopathy

isoflurophate has been researched along with Hepatic Encephalopathy in 1 studies

Isoflurophate: A di-isopropyl-fluorophosphate which is an irreversible cholinesterase inhibitor used to investigate the NERVOUS SYSTEM.

Hepatic Encephalopathy: A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5)

Research Excerpts

ExcerptRelevanceReference
"Portacaval shunting is a model for hepatic encephalopathy that causes chronic hyperammonemia, disruption of metabolic, signaling, and neurotransmitter systems, and progressive morphological changes."1.40Reduced clearance of proteins labeled with diisopropylfluorophosphate in portacaval-shunted rats. ( Cruz, NF; Dienel, GA, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dienel, GA1
Cruz, NF1

Other Studies

1 other study available for isoflurophate and Hepatic Encephalopathy

ArticleYear
Reduced clearance of proteins labeled with diisopropylfluorophosphate in portacaval-shunted rats.
    Metabolic brain disease, 2014, Volume: 29, Issue:4

    Topics: Amino Acids; Animals; Fluorescent Dyes; Hepatic Encephalopathy; Hydrogen-Ion Concentration; Hyperamm

2014